Literature DB >> 16804139

Reports of adverse events from bone drugs prompt caution.

Bridget M Kuehn.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16804139     DOI： 10.1001/jama.295.24.2833

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  11 in total

1.  Bisphosphonates cause osteonecrosis of the jaw-like disease in mice.

Authors:  Yanming Bi; Yamei Gao; Driss Ehirchiou; Chunzhang Cao; Takashi Kikuiri; Anh Le; Songtao Shi; Li Zhang
Journal:  Am J Pathol       Date:  2010-05-14       Impact factor: 4.307

2.  Mandible matrix necrosis in beagle dogs after 3 years of daily oral bisphosphonate treatment.

Authors:  Matthew R Allen; David B Burr
Journal:  J Oral Maxillofac Surg       Date:  2008-05       Impact factor: 1.895

3.  An in vitro assessment of fibroblast and osteoblast response to alendronate-modified titanium and the potential for decreasing fibrous encapsulation.

Authors:  Xuefeng Hu; Koon Gee Neoh; Zhilong Shi; En-Tang Kang; Wilson Wang
Journal:  Tissue Eng Part A       Date:  2013-04-26       Impact factor: 3.845

4.  Subtrochanteric Femoral Insufficiency Fracture Following Bisphosphonate Therapy for Osseous Metastases.

Authors:  Lisabeth A Bush; Felix S Chew
Journal:  Radiol Case Rep       Date:  2015-12-07

Review 5.  Systematic review of trends in prophylaxis of corticosteroid-induced osteoporosis: the need for standard audit guidelines.

Authors:  M Duyvendak; M Naunton; E N van Roon; G A W Bruyn; J R B J Brouwers
Journal:  Osteoporos Int       Date:  2008-07-16       Impact factor: 4.507

Review 6.  Intermittent bisphosphonate therapy in postmenopausal osteoporosis: progress to date.

Authors:  Jean-Yves Reginster; Olivier Malaise; Audrey Neuprez; Victor-Emmanuel Jouret; Pierre Close
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

7.  Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonate-related osteonecrosis of the jaw-like disease in mice.

Authors:  Takashi Kikuiri; Insoo Kim; Takyoshi Yamaza; Kentaro Akiyama; Qunzhou Zhang; Yunsheng Li; Chider Chen; WanJun Chen; Songlin Wang; Anh D Le; Songtao Shi
Journal:  J Bone Miner Res       Date:  2010-07       Impact factor: 6.741

8.  Cancer treatment dosing regimens of zoledronic acid result in near-complete suppression of mandible intracortical bone remodeling in beagle dogs.

Authors:  Matthew R Allen; Daniel J Kubek; David B Burr
Journal:  J Bone Miner Res       Date:  2010-01       Impact factor: 6.741

9.  Prognosis factors in the treatment of bisphosphonate-related osteonecrosis of the jaw - Prognostic factors in the treatment of BRONJ.

Authors:  Daigo Yoshiga; Ikuo Nakamichi; Yoshihiro Yamashita; Noriaki Yamamoto; Kensuke Yamauchi; Shinnosuke Nogami; Takeshi Kaneuji; Sho Mitsugi; Kenkou Tanaka; Yoshihiro Kataoka; Takuma Sakurai; Hiroyasu Kiyomiya; Ikuya Miyamoto; Tetsu Takahashi
Journal:  J Clin Exp Dent       Date:  2014-02-01

10.  Could the Combined Administration of Bone Antiresorptive Drug, Taxanes, and Corticosteroids Worsen Medication Related Osteonecrosis of the Jaws in Cancer Patients?

Authors:  Giacomo Oteri; Giuseppina Campisi; Vera Panzarella; Ilaria Morreale; Riccardo Nucera; Olga Di Fede; Antonio Picone; Antonia Marcianò
Journal:  Biomed Res Int       Date:  2018-05-29       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.